Assessing prognosis in IgA nephropathy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 35738837.
- Also identified by DOI 10.1016/j.kint.2022.04.018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Assessing the prognosis is essential in chronic diseases, such as IgA nephropathy. The 2021 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend the "International IgAN Prediction Tool" (available at www.qxmd.com) for this. The key limitation was that the tool was only validated at the time of the kidney biopsy. An improved algorithm is now described, which allows assessing the prognosis at 1 or 2 years after biopsy. Herein, we review the strengths, limitations, and potential clinical usefulness of this new prediction tool.
Medical subject headings
- Glomerulonephritis, IGA
- Kidney Failure, Chronic